Cargando…

Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival

PURPOSE: Adjuvant chemotherapy is recommended after curative surgery in patients with colon cancer of high-risk stage II and stage III. However, a considerable number of patients cannot complete the scheduled adjuvant treatment for various reasons. This study investigates the hindering factors to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jieun, Yoo, Ri Na, Cho, Hyeon-Min, Kye, Bong-Hyeon, Kim, Hyung Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Surgical Oncology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942742/ https://www.ncbi.nlm.nih.gov/pubmed/36945205 http://dx.doi.org/10.14216/kjco.21002

Ejemplares similares

Mortality risk factor analysis in colonic perforation: would retroperitoneal contamination increase mortality in colonic perforation?
por: Yoo, Ri Na, et al.
Publicado: (2017)

Management of obstructive colon cancer: Current status, obstacles, and future directions
por: Yoo, Ri-Na, et al.
Publicado: (2021)

Rapid transit in the left-sided colon is related to poor defecatory function at early period after stoma closure
por: Yoo, Ri Na, et al.
Publicado: (2020)

The effect of laparoscopic surgery in stage II and III right-sided colon cancer: a retrospective study
por: Kye, Bong-Hyeon, et al.
Publicado: (2012)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

The Effect of Biofeedback Therapy on Anorectal Function After the Reversal of Temporary Stoma When Administered During the Temporary Stoma Period in Rectal Cancer Patients With Sphincter-Saving Surgery: The Interim Report of a Prospective Randomized Controlled Trial
por: Kye, Bong-Hyeon, et al.
Publicado: (2016)

The pattern of bowel dysfunction in patients with rectal cancer following the multimodal treatment: anorectal manometric measurements at before and after chemoradiation therapy, and postoperative 1 year
por: Yoo, Ri Na, et al.
Publicado: (2023)

Assessment of Colorectal Anastomosis with Intraoperative Colonoscopy: Its Role in Reducing Anastomotic Complications
por: Yoo, Ri-Na, et al.
Publicado: (2023)

Prompt Management Is Most Important for Colonic Perforation After Colonoscopy
por: Kim, Hyun-Ho, et al.
Publicado: (2014)

Effect of Biofeedback Therapy during Temporary Stoma Period in Rectal Cancer Patients: A Prospective Randomized Trial
por: Cho, Hyeon-Min, et al.
Publicado: (2021)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

One-year experience of robotic transabdominal preperitoneal approach in a single institute: 2 different surgeons with different levels of experience
por: Yoo, Ri Na, et al.
Publicado: (2023)

Reappraisal of the Lymphatic Drainage System of the Distal Rectum: Functional Lymphatic Flow into the Presacral Space and Its Clinical Implication in Rectal Cancer Treatment
por: Yoo, Ri-Na, et al.
Publicado: (2023)

Treatment of Right Colonic Diverticulitis: The Role of Nonoperative Treatment
por: Kim, Ma Ru, et al.
Publicado: (2010)

Survival Outcomes after Elective or Emergency Surgery for Synchronous Stage IV Colorectal Cancer
por: Mun, Ji-Yeon, et al.
Publicado: (2022)

How Much Colonic Redundancy Could Be Obtained by Splenic Flexure Mobilization in Laparoscopic Anterior or Low Anterior Resection?
por: Kye, Bong-Hyeon, et al.
Publicado: (2014)

Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients
por: Morris, M, et al.
Publicado: (2007)

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans
por: Aspinall, Sherrie L, et al.
Publicado: (2015)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
por: Gao, Peng, et al.
Publicado: (2018)

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer
por: Jeong, Woon Kyung, et al.
Publicado: (2015)

Shortening adjuvant chemotherapy in stage III colon cancer: are we ready for a change?
por: Roda, Desamparados, et al.
Publicado: (2018)

Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
por: Boakye, Daniel, et al.
Publicado: (2021)

Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer
por: Boyne, Devon J., et al.
Publicado: (2021)

Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy
por: Han, Song-Hee, et al.
Publicado: (2019)

Addition of V-Stage to Conventional TNM Staging to Create the TNVM Staging System for Accurate Prediction of Prognosis in Colon Cancer: A Multi-Institutional Retrospective Cohort Study
por: Bae, Jung Hoon, et al.
Publicado: (2021)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

A case of inflammatory myofibroblastic tumor originated from the greater omentum in young adult
por: Kye, Bong Hyeon, et al.
Publicado: (2012)

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70
por: Lu, Chieh-Sheng, et al.
Publicado: (2015)

Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer
por: van Waalwijk, Maren A., et al.
Publicado: (2011)

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
por: Batra, Atul, et al.
Publicado: (2020)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
por: Tan, Sarah Xinhui, et al.
Publicado: (2023)

Short- and long-term outcomes of laparoscopic segmental left colectomy for splenic flexure colon cancer: comparison with propensity score matching
por: Kim, Moon Jin, et al.
Publicado: (2021)

Short-term outcomes of Early versus conventional adjuvant chemotherapy in stage III colon cancer: randomized clinical trial
por: Lee, Kyung Ha, et al.
Publicado: (2023)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b6463tej62s2rn26e1bjbu0fep